You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LN

Showing 1 - 25 of 2,238
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Melanoma Trial in New York (Lifileucel (LN-144))

Recruiting
  • Metastatic Melanoma
  • Lifileucel (LN-144)
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Jan 23, 2023

Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

Recruiting
  • Bone Sarcoma
  • +15 more
  • Aldesleukin
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 3, 2022

Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

Recruiting
  • Uveal Melanoma
  • +3 more
  • Lifileucel (LN-144)
  • Harrison, New York
  • +1 more
Nov 8, 2022

18F-LN1 PET/CT in Urothelial Carcinomas

Recruiting
  • Urothelial Carcinoma
    • Chengdu, Sichuan, China
      Departments of Nuclear Medicine, Sichuan Provincial People's Hos
    Nov 2, 2023

    Developmental Dysplasia of the Hip Trial (Kirschner wire)

    Not yet recruiting
    • Developmental Dysplasia of the Hip
    • Kirschner wire
    • (no location specified)
    Apr 20, 2023

    Unresectable Melanoma, Metastatic Melanoma Trial in Orlando, Louisville, New York (Lifileucel)

    Available
    • Unresectable Melanoma
    • Metastatic Melanoma
    • Lifileucel
    • Orlando, Florida
    • +2 more
    Jul 19, 2022

    Lupus Nephritis Trial in Alexandria (Dapagliflozin 10mg Tab orally once daily)

    Not yet recruiting
    • Lupus Nephritis
    • Dapagliflozin 10mg Tab orally once daily
    • Alexandria, Egypt
      Ain Shams University
    Oct 27, 2023

    Oxidative Stress Trial in Mumbai (LN-OS-22, Maltodextrin)

    Recruiting
    • Oxidative Stress
    • LN-OS-22
    • Maltodextrin
    • Mumbai, Maharashtra, India
    • +1 more
    Jun 17, 2022

    A Lymph Node Metastasis Predictor (LN-MASTER) in Rectal Cancer

    Completed
    • Rectum Cancer
    • The hospital where the treatment is performed
    • (no location specified)
    Aug 6, 2022

    After Completing or Abandoning Hysterectomy in Cervical Cancer

    Completed
    • Uterine Cervical Neoplasms
    • Cervical procedure
    • Prague, MUDr., Czechia
      Gynecologic Oncology Center, Department of Obstetrics and Gyneco
    Aug 7, 2022

    Metastatic Melanoma, Unresectable Melanoma, Melanoma Trial (Lifileucel plus Pembrolizumab, Pembrolizumab with Optional Crossover

    Not yet recruiting
    • Metastatic Melanoma
    • +2 more
    • Lifileucel plus Pembrolizumab
    • Pembrolizumab with Optional Crossover Period
    • (no location specified)
    Feb 13, 2023

    Belimumab In Prevention of LN

    Not yet recruiting
    • Whether Belimumab Could Reduce 2-year Risk of New-onset Lupus Nephritis
    • (no location specified)
    Oct 14, 2022

    Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, NSCLC Trial in Worldwide (Lifileucel, LN-145, Pembrolizumab)

    Recruiting
    • Metastatic Melanoma
    • +2 more
    • Lifileucel
    • +5 more
    • La Jolla, California
    • +44 more
    Dec 16, 2022

    Carcinoma, Lobular Trial ([18F]fluoroestradiol (FES))

    Not yet recruiting
    • Carcinoma, Lobular
    • [18F]fluoroestradiol (FES)
    • (no location specified)
    Jul 18, 2023

    Metastatic Triple Negative Breast Cancer Trial in New Haven (Tumor infiltrating lymphocytes (TIL) LN-145)

    Recruiting
    • Metastatic Triple Negative Breast Cancer
    • Tumor infiltrating lymphocytes (TIL) LN-145
    • New Haven, Connecticut
      Yale School of Medicine
    Jul 20, 2022

    Invasive Breast Cancer, Ipsilateral Recurrence, Sentinel Lymph Node Biopsy Trial in France (Sentinel LN in breast cancer

    Terminated
    • Invasive Breast Cancer
    • +2 more
    • Sentinel LN in breast cancer recurrence
    • Bordeaux, France
    • +8 more
    Apr 19, 2022

    Use of Continence Care Protocol in UK Nursing Homes.

    Completed
    • Urinary Incontinence Due to Cognitive Impairment
    • Urinary Incontinence
    • Skin and leakage protocol
    • Lincoln, United Kingdom
      Lincolnshire Community Health Services NHS Trust
    Oct 19, 2023

    Artificial Intelligence, Endobronchial Ultrasound, Elastography Trial in Hamilton (EBUS-Elastography)

    Completed
    • Artificial Intelligence
    • +4 more
    • EBUS-Elastography
    • Hamilton, Ontario, Canada
      St. Joseph's Healthcare Hamilton
    Jul 25, 2022

    Locally Advanced Melanoma, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8

    Recruiting
    • Locally Advanced Melanoma
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 18, 2022

    Percutaneous Coronary Intervention Trial in Seoul

    Not yet recruiting
    • Percutaneous Coronary Intervention
      • Seoul, Korea, Republic of
      • +1 more
      Aug 1, 2023

      Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in

      Not yet recruiting
      • Clinical Stage IV Cutaneous Melanoma AJCC v8
      • +3 more
      • Biospecimen Collection
      • +8 more
      • Kansas City, Kansas
        University of Kansas Cancer Center
      Nov 27, 2023

      Metastatic Non Small Cell Lung Cancer Trial in Canada, Netherlands, United States (LN-145)

      Recruiting
      • Metastatic Non Small Cell Lung Cancer
      • LN-145
      • Duarte, California
      • +40 more
      Oct 20, 2022

      Systemic Lupus Erythematosus, Lupus Nephritis Trial in Nanjing (Human umbilical cord mesenchymal stem cells, Interleukin-2)

      Recruiting
      • Systemic Lupus Erythematosus
      • Lupus Nephritis
      • Nanjing, Jiangsu, China
        The Affiliated Nanjing Drum Tower Hospital of Nanjing University
      Nov 20, 2022

      Coronary Heart Disease Trial in Coventry (Polar Ignite Wearable Activity Monitor)

      Recruiting
      • Coronary Heart Disease
      • Polar Ignite Wearable Activity Monitor
      • Coventry, West Midlands, United Kingdom
        Atrium Health Limited
      Jun 17, 2022

      Cervical Carcinoma Trial in Worldwide (LN-145, LN-145 + pembrolizumab)

      Recruiting
      • Cervical Carcinoma
      • LN-145
      • LN-145 + pembrolizumab
      • Phoenix, Arizona
      • +39 more
      Aug 16, 2022